Quarterly report [Sections 13 or 15(d)]

CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)

v3.25.2
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Pre-funded warrants
Common Stock
Pre-funded warrants
Additional Paid-In Capital
Pre-funded warrants
Preferred Stock
Series E-2 Preferred Stock
Preferred Stock
Series E-3 preferred stock
Preferred Stock
Common Stock
Series E-2 Preferred Stock
Common Stock
Series E-3 preferred stock
Common Stock
Additional Paid-In Capital
Series E-2 Preferred Stock
Additional Paid-In Capital
Series E-3 preferred stock
Additional Paid-In Capital
Accumulated Deficit
Series D preferred stock
Total
Balance beginning at Dec. 31, 2023           $ 4,677,632     $ 7     $ 182,924,410 $ (202,761,017)   $ (15,158,968)
Balance beginning (in shares) at Dec. 31, 2023           319.76     691,470            
Balance beginning Series D preferred stock at Dec. 31, 2023                           $ 1,382,023  
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2023                           111.11  
Stock-based compensation                       454,363     454,363
Exercise of warrants for common stock                       2,298,143     2,298,143
Exercise of warrants for common stock (in shares)                 18,239            
Exercise of warrants for preferred stock, net of issuance costs           $ 47,577,000                 47,577,000
Exercise of warrants for preferred stock, net of issuance costs (in shares)           2,205                  
Conversion of preferred stock into common stock $ 1 $ 3,972,539 $ 3,972,540 $ (1,203,346) $ (33,983,571)     $ 3   $ 1,203,346 $ 33,983,568        
Conversion of preferred stock into common stock (in shares) 35,971     82.26 (1,575)   30,132 329,670              
Net loss                         (26,641,983)   (26,641,983)
Balance ending Series D preferred stock at Mar. 31, 2024                           $ 1,382,023  
Balance ending Series D preferred stock (in shares) at Mar. 31, 2024                           111.11  
Balance ending at Mar. 31, 2024           $ 17,067,715     $ 11     224,836,369 (229,403,000)   12,501,095
Balance ending (in shares) at Mar. 31, 2024           867.5     1,105,482            
Balance beginning at Dec. 31, 2023           $ 4,677,632     $ 7     182,924,410 (202,761,017)   (15,158,968)
Balance beginning (in shares) at Dec. 31, 2023           319.76     691,470            
Balance beginning Series D preferred stock at Dec. 31, 2023                           $ 1,382,023  
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2023                           111.11  
Net loss                             (27,561,355)
Balance ending Series D preferred stock at Jun. 30, 2024                           $ 1,382,023  
Balance ending Series D preferred stock (in shares) at Jun. 30, 2024                           111.11  
Balance ending at Jun. 30, 2024           $ 7,843,603     $ 12     234,859,729 (230,322,371)   12,380,973
Balance ending (in shares) at Jun. 30, 2024           440     1,194,964            
Balance beginning at Dec. 31, 2023           $ 4,677,632     $ 7     182,924,410 (202,761,017)   (15,158,968)
Balance beginning (in shares) at Dec. 31, 2023           319.76     691,470            
Balance beginning Series D preferred stock at Dec. 31, 2023                           $ 1,382,023  
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2023                           111.11  
Balance ending Series D preferred stock at Dec. 31, 2024                           $ 1,382,023  
Balance ending Series D preferred stock (in shares) at Dec. 31, 2024                           111.11  
Balance ending at Dec. 31, 2024           $ 520,778     $ 15     261,116,351 (247,342,463)   14,294,681
Balance ending (in shares) at Dec. 31, 2024           35.6     1,535,996            
Balance beginning at Mar. 31, 2024           $ 17,067,715     $ 11     224,836,369 (229,403,000)   12,501,095
Balance beginning (in shares) at Mar. 31, 2024           867.5     1,105,482            
Balance beginning Series D preferred stock at Mar. 31, 2024                           $ 1,382,023  
Balance beginning Series D preferred stock (in shares) at Mar. 31, 2024                           111.11  
Stock-based compensation                       799,249     799,249
Conversion of preferred stock into common stock         $ (9,224,112)     $ 1     $ 9,224,111        
Conversion of preferred stock into common stock (in shares)         (427.5)     89,482              
Net loss                         (919,371)   (919,371)
Balance ending Series D preferred stock at Jun. 30, 2024                           $ 1,382,023  
Balance ending Series D preferred stock (in shares) at Jun. 30, 2024                           111.11  
Balance ending at Jun. 30, 2024           $ 7,843,603     $ 12     234,859,729 (230,322,371)   12,380,973
Balance ending (in shares) at Jun. 30, 2024           440     1,194,964            
Balance beginning at Dec. 31, 2024           $ 520,778     $ 15     261,116,351 (247,342,463)   14,294,681
Balance beginning (in shares) at Dec. 31, 2024           35.6     1,535,996            
Balance beginning Series D preferred stock at Dec. 31, 2024                           $ 1,382,023  
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2024                           111.11  
Stock-based compensation                       562,737     562,737
Net loss                         (6,604,029)   (6,604,029)
Balance ending Series D preferred stock at Mar. 31, 2025                           $ 1,382,023  
Balance ending Series D preferred stock (in shares) at Mar. 31, 2025                           111.11  
Balance ending at Mar. 31, 2025           $ 520,778     $ 15     261,679,088 (253,946,492)   8,253,389
Balance ending (in shares) at Mar. 31, 2025           35.6     1,535,996            
Balance beginning at Dec. 31, 2024           $ 520,778     $ 15     261,116,351 (247,342,463)   14,294,681
Balance beginning (in shares) at Dec. 31, 2024           35.6     1,535,996            
Balance beginning Series D preferred stock at Dec. 31, 2024                           $ 1,382,023  
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2024                           111.11  
Conversion of preferred stock into common stock (in shares)               461,538              
Net loss                             (12,051,940)
Balance ending Series D preferred stock at Jun. 30, 2025                           $ 1,382,023  
Balance ending Series D preferred stock (in shares) at Jun. 30, 2025                           111.11  
Balance ending at Jun. 30, 2025           $ 520,778     $ 18     264,958,619 (259,394,403)   6,085,012
Balance ending (in shares) at Jun. 30, 2025           35.6     1,812,040            
Balance beginning at Mar. 31, 2025           $ 520,778     $ 15     261,679,088 (253,946,492)   8,253,389
Balance beginning (in shares) at Mar. 31, 2025           35.6     1,535,996            
Balance beginning Series D preferred stock at Mar. 31, 2025                           $ 1,382,023  
Balance beginning Series D preferred stock (in shares) at Mar. 31, 2025                           111.11  
Stock-based compensation                       565,391     565,391
Exercise of warrants for common stock                 $ 3     2,714,140     2,714,140
Exercise of warrants for common stock (in shares)                 276,044            
Net loss                         (5,447,911)   (5,447,911)
Balance ending Series D preferred stock at Jun. 30, 2025                           $ 1,382,023  
Balance ending Series D preferred stock (in shares) at Jun. 30, 2025                           111.11  
Balance ending at Jun. 30, 2025           $ 520,778     $ 18     $ 264,958,619 $ (259,394,403)   $ 6,085,012
Balance ending (in shares) at Jun. 30, 2025           35.6     1,812,040